Literature DB >> 16930255

Rehabilitation for cognitive impairments after cerebral malaria in African children: strategies and limitations.

Paul Bangirana1, Richard Idro, Chandy C John, Michael J Boivin.   

Abstract

Cerebral malaria results in short- to long-term cognitive impairments in many of its child survivors. Although some of the risk factors for impairments have been identified, no attempts have been made to address the plight of those who develop cognitive impairments. This paper discusses the burden of cognitive impairment caused by cerebral malaria and suggests some rehabilitation strategies based on brain injury and cognitive rehabilitation studies. Potential cognitive rehabilitation solutions such as cognitive exercises, environmental enrichment, nutritional supplementation, physical therapy and speech therapy are highlighted. The limitations of implementing these interventions and solutions are discussed in light of the limited human resources and infrastructure of the developing countries that are malaria endemic.

Entities:  

Mesh:

Year:  2006        PMID: 16930255     DOI: 10.1111/j.1365-3156.2006.01685.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  12 in total

1.  Immediate neuropsychological and behavioral benefits of computerized cognitive rehabilitation in Ugandan pediatric cerebral malaria survivors.

Authors:  Paul Bangirana; Bruno Giordani; Chandy C John; Connie Page; Robert O Opoka; Michael J Boivin
Journal:  J Dev Behav Pediatr       Date:  2009-08       Impact factor: 2.225

2.  Mental Health Diagnostic Frameworks, Imputed Causes of Mental Illness, and Alternative Treatments in Northern Tanzania: Exploring Mental Health Providers' Perspectives.

Authors:  Brandon A Knettel; Janvier Rugira; Joseph A Cornett
Journal:  Cult Med Psychiatry       Date:  2018-09

3.  A preliminary examination of the construct validity of the KABC-II in Ugandan children with a history of cerebral malaria.

Authors:  P Bangirana; P Allebeck; B Giordani; C C John; O R Opoka; J Byarugaba; A Ehnvall; M J Boivin
Journal:  Afr Health Sci       Date:  2009-09       Impact factor: 0.927

4.  Developmental outcomes in Malawian children with retinopathy-positive cerebral malaria.

Authors:  Michael J Boivin; Melissa J Gladstone; Maclean Vokhiwa; Gretchen L Birbeck; Jed G Magen; Connie Page; Margaret Semrud-Clikeman; Felix Kauye; Terrie E Taylor
Journal:  Trop Med Int Health       Date:  2010-12-08       Impact factor: 2.622

Review 5.  Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.

Authors:  Richard Idro; Kevin Marsh; Chandy C John; Charles R J Newton
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

Review 6.  The 'hidden' burden of malaria: cognitive impairment following infection.

Authors:  Sumadhya D Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  Malar J       Date:  2010-12-20       Impact factor: 2.979

7.  Cognition, behaviour and academic skills after cognitive rehabilitation in Ugandan children surviving severe malaria: a randomised trial.

Authors:  Paul Bangirana; Peter Allebeck; Michael J Boivin; Chandy C John; Connie Page; Anna Ehnvall; Seggane Musisi
Journal:  BMC Neurol       Date:  2011-08-04       Impact factor: 2.474

8.  Survey of rehabilitation support for children 0-15 years in a rural part of Kenya.

Authors:  Karen Bunning; Joseph K Gona; Victor Odera-Mung'ala; Charles R Newton; Jo-Anne Geere; Chia Swee Hong; Sally Hartley
Journal:  Disabil Rehabil       Date:  2013-09-02       Impact factor: 3.033

9.  Global Need for Physical Rehabilitation: Systematic Analysis from the Global Burden of Disease Study 2017.

Authors:  Tiago S Jesus; Michel D Landry; Helen Hoenig
Journal:  Int J Environ Res Public Health       Date:  2019-03-19       Impact factor: 3.390

10.  Socioeconomic predictors of cognition in Ugandan children: implications for community interventions.

Authors:  Paul Bangirana; Chandy C John; Richard Idro; Robert O Opoka; Justus Byarugaba; Anne M Jurek; Michael J Boivin
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.